Analytical Data
-
Gene name
UTS2
- Application
-
Alternative Names
PRO1068; U-II; UCN2; UII; Urotensin 2 preproProtein isoform a; Urotensin 2 preproProtein isoform b; Urotensin II; Urotensin-2; UTS2; UTS2_HUMAN; UTSII
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95399
-
Expression Region
114-124 aa
-
AA Sequence
ETPDCFW KYCV
-
Molecular Weight
14.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UTS2 (Urotensin II) is a peptide that plays a crucial role in various physiological and pathological processes, including cardiovascular regulation, renal function, and neuroprotection. Discovered as a potent vasoconstrictor, UTS2 is involved in several signaling pathways that affect blood pressure and cardiac contractility. Recent studies highlight its potential implications in diseases such as heart failure, hypertension, and metabolic disorders. The recombinant expression of UTS2 allows researchers to investigate its functional properties, receptor interactions, and biological effects in detail. Moreover, understanding UTS2's mechanism of action could lead to the development of novel therapeutic strategies targeting related disorders. The advancement in recombinant protein technologies has facilitated the production of UTS2 variants for biochemical and pharmaceutical applications, making it essential to explore its structure-function relationship. This ongoing research contributes to a broader understanding of urotensin's role in human health and disease, paving the way for innovative approaches in treating conditions associated with dysregulated UTS2 signaling.
